BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35522890)

  • 1. MYB RNA In Situ Hybridization Is a Useful Diagnostic Tool to Distinguish Breast Adenoid Cystic Carcinoma From Other Triple-negative Breast Carcinomas.
    Butcher MR; White MJ; Rooper LM; Argani P; Cimino-Mathews A
    Am J Surg Pathol; 2022 Jul; 46(7):878-888. PubMed ID: 35522890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYB RNA In Situ Hybridization Facilitates Sensitive and Specific Diagnosis of Adenoid Cystic Carcinoma Regardless of Translocation Status.
    Rooper LM; Lombardo KA; Oliai BR; Ha PK; Bishop JA
    Am J Surg Pathol; 2021 Apr; 45(4):488-497. PubMed ID: 33165092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH.
    Poling JS; Yonescu R; Subhawong AP; Sharma R; Argani P; Ning Y; Cimino-Mathews A
    Am J Surg Pathol; 2017 Jul; 41(7):973-979. PubMed ID: 28498281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
    Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
    J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinoma.
    Tadi S; Cheung VK; Lee CS; Nguyen K; Luk PP; Low TH; Palme C; Clark J; Gupta R
    Pathology; 2023 Jun; 55(4):456-465. PubMed ID: 37055331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in MYB expression and gene abnormalities further confirm that salivary cribriform basal cell tumors and adenoid cystic carcinoma are two distinct tumor entities.
    Tian Z; Li L; Zhang CY; Gu T; Li J
    J Oral Pathol Med; 2016 Oct; 45(9):698-703. PubMed ID: 26711587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
    Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
    Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles.
    Andreasen S; Tan Q; Agander TK; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; von Holstein SL; Wessel I; Heegaard S; Homøe P
    Mod Pathol; 2018 Aug; 31(8):1211-1225. PubMed ID: 29467480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic landscape of adenoid cystic carcinoma of the breast.
    Martelotto LG; De Filippo MR; Ng CK; Natrajan R; Fuhrmann L; Cyrta J; Piscuoglio S; Wen HC; Lim RS; Shen R; Schultheis AM; Wen YH; Edelweiss M; Mariani O; Stenman G; Chan TA; Colombo PE; Norton L; Vincent-Salomon A; Reis-Filho JS; Weigelt B
    J Pathol; 2015 Oct; 237(2):179-89. PubMed ID: 26095796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
    Fujii K; Murase T; Beppu S; Saida K; Takino H; Masaki A; Ijichi K; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Inagaki H
    Histopathology; 2017 Nov; 71(5):823-834. PubMed ID: 28594149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYB Translocation Status in Salivary Gland Epithelial-Myoepithelial Carcinoma: Evaluation of Classic, Variant, and Hybrid Forms.
    Bishop JA; Westra WH
    Am J Surg Pathol; 2018 Mar; 42(3):319-325. PubMed ID: 29135517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
    Kim J; Geyer FC; Martelotto LG; Ng CK; Lim RS; Selenica P; Li A; Pareja F; Fusco N; Edelweiss M; Kumar R; Gularte-Merida R; Forbes AN; Khurana E; Mariani O; Badve S; Vincent-Salomon A; Norton L; Reis-Filho JS; Weigelt B
    J Pathol; 2018 Feb; 244(2):143-150. PubMed ID: 29149504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoid Cystic Carcinoma With Striking Tubular Hypereosinophilia: A Unique Pattern Associated With Nonparotid Location and Both Canonical and Novel EWSR1::MYB and FUS::MYB Fusions.
    Weinreb I; Rooper LM; Dickson BC; Hahn E; Perez-Ordonez B; Smith SM; Lewis JS; Skalova A; Baněčková M; Wakely PE; Thompson LDR; Rupp NJ; Freiberger SN; Koduru P; Gagan J; Bishop JA
    Am J Surg Pathol; 2023 Apr; 47(4):497-503. PubMed ID: 36920022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland.
    Salem A; Wu Y; Albarracin CT; Middleton LP; Kalhor N; Peng Y; Huang X; Aung PP; Chen H; Sahin AA; Ding Q
    Hum Pathol; 2024 Mar; 145():42-47. PubMed ID: 38262580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Adenoid Cystic Carcinoma with Striking Tubular Hypereosinophilia by MYB and EWSR1 Breakapart Fluorescence In Situ Hybridization.
    Yadav U; Mahendru R; Sharma J; Kakkar A
    Head Neck Pathol; 2023 Dec; 17(4):940-951. PubMed ID: 38010473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16 Immunoexpression in sinonasal and nasopharyngeal adenoid cystic carcinomas: a potential pitfall in ruling out HPV-related multiphenotypic sinonasal carcinoma.
    Antony VM; Kakkar A; Sikka K; Thakar A; Deo SVS; Bishop JA; Jain D
    Histopathology; 2020 Dec; 77(6):989-993. PubMed ID: 32671903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYB gene abnormalities t(6;9) in adenoid cystic carcinoma fine-needle aspiration biopsy using fluorescence in situ hybridization.
    Hudson JB; Collins BT
    Arch Pathol Lab Med; 2014 Mar; 138(3):403-9. PubMed ID: 24576033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers.
    Rabban JT; Swain RS; Zaloudek CJ; Chase DR; Chen YY
    Mod Pathol; 2006 Oct; 19(10):1351-7. PubMed ID: 16810311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
    West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT
    Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.
    Fusco N; Geyer FC; De Filippo MR; Martelotto LG; Ng CK; Piscuoglio S; Guerini-Rocco E; Schultheis AM; Fuhrmann L; Wang L; Jungbluth AA; Burke KA; Lim RS; Vincent-Salomon A; Bamba M; Moritani S; Badve SS; Ichihara S; Ellis IO; Reis-Filho JS; Weigelt B
    Mod Pathol; 2016 Nov; 29(11):1292-1305. PubMed ID: 27491809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.